Skip to content
Facebook Twitter Linkedin Pinterest Youtube Instagram

Bridging the Gap Between Participants and Clinical Trials

  • Who We Are
  • FAQs
  • Jobs
  • Blog
  • Contact
  • Member’s Login
Menu
  • Who We Are
  • FAQs
  • Jobs
  • Blog
  • Contact
  • Member’s Login
  • Clinical Trials
    • Recruiting
    • Active, Not Recruiting
    • Closed: follow-up continuing
    • Closed: follow-up complete
    • Completed
  • Trial Sites
  • Join Our Community
Menu
  • Clinical Trials
    • Recruiting
    • Active, Not Recruiting
    • Closed: follow-up continuing
    • Closed: follow-up complete
    • Completed
  • Trial Sites
  • Join Our Community

A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Oral ASN51 in Healthy Young Adult and Elderly Subjects and Elderly Subjects With Alzheimer’s Disease

Read More »

A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost

Read More »

The SNaPP Pilot Study: A feasibility and pilot study for a multi-centre, patient- and observer-blinded randomised controlled trial of sugammadex or neostigmine to reverse neuromuscular blockade in adult patients having abdominal and thoracic surgery under general anaesthesia

Read More »

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension (OHT)

Read More »

Effects of SGLT-2 inhibition on Sympathetic Nervous System Activity in Humans

Read More »

Neuroinflammation in Hypertension Study (MINIHT)

Read More »

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety (PRECISION)

Read More »

SPYRAL HTN-ON-MED Study

Read More »

Expanded PrEP Implementation in Communities in NSW (EPIC-NSW)

Read More »

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)

Read More »
« Previous Next »

AustralianClinicalTrials.com

  • Who We Are
  • FAQs
  • Blog
  • Contact Us
Menu
  • Who We Are
  • FAQs
  • Blog
  • Contact Us

Community

  • Who We Are
  • FAQs
  • Blog
  • Contact Us
Menu
  • Who We Are
  • FAQs
  • Blog
  • Contact Us

Start by doing what’s necessary; then do what’s possible; and suddenly you are doing the impossible.

Francis of Assisi

Copyright © 2023 Australian Clinical Trials. Terms of Use  /  Privacy Policy

Facebook Twitter Linkedin Pinterest Youtube Instagram